【24h】

Plasma and erythrocyte total antioxidant status in patients with benign and malign breast disease.

机译:血浆和红细胞总抗氧化状态良性和恶性乳腺疾病患者。

获取原文
获取原文并翻译 | 示例
           

摘要

The study was carried out on 25 women with breast cancer, 25 with fibrocystic breast disease and 19 healthy subjects. Antioxidant enzyme activities and total antioxidant status (AOX) were measured in erythrocyte and plasma of patients and healthies. Among the studied parameters, the erythrocyte Glutathione Peroxidase (GSH-Px) and Catalase (CAT) activities of patients with breast cancer were significantly different as compared to the control group values (p < 0.002 and p < 0.001) respectively. There was no correlation between total antioxidant status and any of these enzymes in erythrocyte and plasma activities of subjects. However, the positive correlation was found between erythrocyte and plasma Superoxide Dismutase [SOD(CuZn)] activities in all groups. Our results indicate that enzymatic and nonenzymatic antioxidants are differentially altered in human breast tumors. Since the total antioxidant status measurement isn't sufficient to evaluate the oxidant damage in breast disease, antioxidant enzymes must be measured separately in order to get additional information.
机译:这项研究是进行25的女性乳房与乳腺纤维囊性乳腺疾病和癌症,25日19健康受试者。和总抗氧化状态(AOX)测量在病人和红细胞和血浆健康的。红细胞谷胱甘肽过氧化物酶(氧化酶)和过氧化氢酶(CAT)的乳腺癌患者的活动癌症是相比明显不同对照组值(p < 0.002和p <分别为0.001)。总抗氧化状态,这些之间在红细胞和血浆酶的活动科目。发现红细胞和血浆超氧化物之间歧化酶(SOD (CuZn)]在所有团体活动。我们的结果表明,酶和非酶的抗氧化剂是不同改变人类乳腺肿瘤。抗氧化状态测量不是充分的探讨氧化剂破坏乳腺疾病,抗氧化酶必须单独测量为了得到更多的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号